Bondlido is a drug-in-adhesive topical delivery system containing 200mg of lidocaine, an amide local anesthetic.
Vizz eye drops contain a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, resulting in a pinhole effect that extends focus depth to improve vision in presbyopia.
Advocates for the drug’s use insist it has a strong safety record. HealthDay News — The US Food and Drug Administration (FDA) is reviewing the safety of mifepristone, a drug used in medication ...
Cytokine release syndrome occurred in 33 and 24% of participants in the ATG 2.5- and 0.5mg/kg groups, respectively, and in no participants in the placebo group. HealthDay News — Antithymocyte globulin ...
Twelve conditional recommendations include 1 against 2-hour gastric emptying testing and 1 in favor of 4-hour testing.
The investigation, which first focused on premade chicken pasta meals sold at Walmart and Kroger, is now looking at a similar product sold at Trader Joe’s.
Author says findings support previous clinical trial data showing efficacy of baricitinib in preserving beta cell function in T1D.
The recommended dosage for active PsA and moderate to severe plaque PsO in pediatric patients 6 years (≥40kg) is 100mg administered SC at week 0, 4, and then every 8 weeks thereafter. The Food and ...
Qivigy (immune globulin intravenous, human-kthm) is a ready-to-use, sterile, non-pyrogenic liquid solution of human immune globulin for IV administration.
Treatment with T-DXd resulted in a statistically significant and clinically meaningful improvement in IDFS vs T-DM1. Topline results were announced from a phase 3 trial comparing fam-trastuzumab ...
HealthDay News — A 16-week Mediterranean diet intervention significantly improves psoriasis severity in patients with mild-to-moderate disease receiving stable topical therapy, according to a study ...
Private equity hospitals reduced ED and ICU salary expenditures by 18.2 and 15.9% per inpatient bed day after acquisition, respectively. HealthDay News — hospitals that undergo private equity ...